# The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic Diseases

> **NCT01518959** · PHASE3 · TERMINATED · sponsor: **Semmelweis University** · enrollment: 31 (actual)

## Conditions studied

- Chronic Lymphoid Leukemia

## Interventions

- **DRUG:** Cholecalciferol
- **DRUG:** oleum neutralicum

## Key facts

- **NCT ID:** NCT01518959
- **Lead sponsor:** Semmelweis University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-01
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Insufficient recruitment rate; technical issues with sample storage
- **Last updated:** 2020-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01518959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01518959, "The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic Diseases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01518959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*